Outlook Therapeutics
OTLK
OTLK
66 hedge funds and large institutions have $44.7M invested in Outlook Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.
Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
27
Reduced
10
Closed
7
Calls
$1.64M
Puts
$84K
Net Calls
+$1.56M
Net Calls Change
+$1.47M
Top Buyers
1 |
1
BlackRock
New York
|
$5.58M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$4.57M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.83M |
4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$488K |
5 |
ACM
5
Altium Capital Management
New York
|
$2.89M |